Jean Claude Katte, MD, PhD
Research Fellow
University of Exeter
Featured in the Session: Joint ADA/ISPAD Symposium: A Global Perspective on Pediatric Type 1 Diabetes Screening
When
Monday, June 8
at 8:00 a.m.
Where
La Nouvelle Orleans B (Level 2)
Ernest N. Morial Convention Center
What is your presentation about?
The understanding of the risk, prediction, and pathogenesis of type 1 diabetes has been developed mainly in European populations, with very limited research conducted in native continental African populations. In addition, type 1 diabetes screening programs are rapidly expanding in high-income countries, with none currently established in Africa, despite the potential benefits in settings where rates of diabetic ketoacidosis at presentation and associated mortality are high. This presentation will discuss the reasons for these disparities and propose solutions to reduce these inequities.
How do you hope your presentation will impact diabetes research or care?
The incidence of type 1 diabetes in Africa is increasing, and there is a need for a comprehensive research program that can provide context-appropriate solutions to improve care. My hope is that this presentation will spark discussions that drive concrete steps toward strengthening the role of African research in shaping the global agenda for type 1 diabetes.
How did you become involved with this area of diabetes research or care?
I was fortunate to be one of the general practitioner trainees who attended the very first workshop on type 1 diabetes management in Cameroon in 2011. Since then, I have worked in several clinical and research roles supporting diabetes care. My doctoral research focused on understanding the phenotype and pathogenesis of type 1 diabetes in African populations, working across multiple countries in Africa.